Stocks & Investing
Stocks and Investing
Stocks and Investing
Tue, May 3, 2022
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
[ Tue, May 03rd 2022
] - WOPRAI
Mon, May 2, 2022
[ Mon, May 02nd 2022
] - WOPRAI
[ Mon, May 02nd 2022
] - WOPRAI
[ Mon, May 02nd 2022
] - WOPRAI
[ Mon, May 02nd 2022
] - WOPRAI
[ Mon, May 02nd 2022
] - WOPRAI
Joseph Pantginis Maintained (XBIO) at Strong Buy with Decreased Target to $40 on, May 2nd, 2022
Joseph Pantginis of HC Wainwright & Co., Maintained "Xenetic Biosciences, Inc." (XBIO) at Strong Buy with Decreased Target from $50 to $40 on, May 2nd, 2022.
Joseph, nor any peers, have made any analyst calls on XBIO in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30